M O Symes

1.4k total citations
61 papers, 1.1k citations indexed

About

M O Symes is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, M O Symes has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 23 papers in Oncology and 17 papers in Surgery. Recurrent topics in M O Symes's work include Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (13 papers) and Cancer Research and Treatments (11 papers). M O Symes is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (13 papers) and Cancer Research and Treatments (11 papers). M O Symes collaborates with scholars based in United Kingdom and Hungary. M O Symes's co-authors include Beverley Fermor, H C Umpleby, R C N Williamson, M. F. A. Woodruff, R C Williamson, A G Riddell, J V Lever, Patrick J. Smith, M. Ferro and C R Tribe and has published in prestigious journals such as Nature, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

M O Symes

57 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M O Symes United Kingdom	17	619	439	281	237	121	61	1.1k
Y Gunji Japan	15	232 0.4×	318 0.7×	214 0.8×	495 2.1×	238 2.0×	50	1.1k
S A Rosenberg United States	8	264 0.4×	95 0.2×	336 1.2×	161 0.7×	223 1.8×	10	946
W. Meyenburg Germany	8	308 0.5×	422 1.0×	114 0.4×	87 0.4×	62 0.5×	9	813
Pamela Kimball United States	18	169 0.3×	306 0.7×	234 0.8×	116 0.5×	208 1.7×	56	1.0k
Vincenzo Imperatore Italy	11	476 0.8×	270 0.6×	98 0.3×	354 1.5×	248 2.0×	16	986
Peter Chu United States	17	225 0.4×	184 0.4×	176 0.6×	110 0.5×	218 1.8×	38	946
Hitoshi Kotanagi Japan	18	335 0.5×	377 0.9×	56 0.2×	189 0.8×	171 1.4×	73	875
Charles E. Welander United States	16	192 0.3×	195 0.4×	117 0.4×	77 0.3×	184 1.5×	36	861
Ken‐ichi Mafune Japan	24	266 0.4×	752 1.7×	127 0.5×	539 2.3×	288 2.4×	81	1.4k
K. H. Kurth Netherlands	15	154 0.2×	634 1.4×	110 0.4×	169 0.7×	116 1.0×	42	870

Countries citing papers authored by M O Symes

Since Specialization

Citations

This map shows the geographic impact of M O Symes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M O Symes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M O Symes more than expected).

Fields of papers citing papers by M O Symes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M O Symes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M O Symes. The network helps show where M O Symes may publish in the future.

Co-authorship network of co-authors of M O Symes

This figure shows the co-authorship network connecting the top 25 collaborators of M O Symes. A scholar is included among the top collaborators of M O Symes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M O Symes. M O Symes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nouri, A.M.E. & M O Symes. (1998). Relevance of the immune system in human urological malignancies: prospective for future clinical treatments. Urology. 51(5). 41–49. 6 indexed citations

Collins, C.M.P., et al.. (1993). The effect of α and γ interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro. European Journal of Cancer. 29(13). 1879–1885. 15 indexed citations

Collins, C.M.P., et al.. (1993). Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells. European Journal of Cancer. 29(3). 378–383. 7 indexed citations

Morgan, Anthony, et al.. (1990). The Effect of Verapamil on the Anti-tumour Action of Mitozantrone and Doxorubicin against Renal Carcinoma Cellsin vitro. British Journal of Urology. 66(6). 596–601. 1 indexed citations

Black, M. Jane, et al.. (1989). Inhibition of protein synthesis, pulmonary localization and pulmonary tumour formation by drug-treated tumour cells as a means of predicting their chemosensitivity. Clinical & Experimental Metastasis. 7(4). 427–436. 2 indexed citations

Ferro, M., et al.. (1989). Testing the Chemosensitivity of Renal Carcinoma in vitro. British Journal of Urology. 64(1). 25–29. 1 indexed citations

Ferro, M., David Gillatt, M O Symes, & Patrick J. Smith. (1989). High-dose intravenous estrogen therapy in advanced prostatic carcinoma. Urology. 34(3). 134–138. 46 indexed citations

Ferro, M., et al.. (1988). Effect of Stilboestrol and Testosterone on the Incorporation of ⁷⁵ Selenomethionine by Prostatic Carcinoma Cells. British Journal of Urology. 62(2). 166–172. 12 indexed citations

Symes, M O, et al.. (1987). Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas. British Journal of Cancer. 56(4). 433–437. 28 indexed citations

10.

Symes, M O, et al.. (1978). Adoptive Immunotheraphy adn Radiotherapy in the Treatment of Urinary Bladder Cancer. British Journal of Urology. 50(5). 328–331. 6 indexed citations

11.

Symes, M O, J. P. Mitchell, J. B. M. ROBERTS, et al.. (1978). Transfer of adoptive immunity by intra-arterial injection of tumor-immune pig lymph node cells. Urology. 12(4). 398–401. 10 indexed citations

12.

FENELEY, R. C. L., et al.. (1974). The treatment of advanced bladder cancer with sensitized pig lymphocytes. British journal of surgery. 61(10). 825–827. 16 indexed citations

13.

Symes, M O, et al.. (1973). Immunodepression as a factor during 3‐methylcholanthrene carcinogenesis and subsequent tumour growth in mice. International Journal of Cancer. 11(1). 202–211. 12 indexed citations

14.

Symes, M O & A G Riddell. (1973). The use of immunized pig lymph-node cells in the treatment of patients with advanced malignant disease. British journal of surgery. 60(3). 176–180. 20 indexed citations

15.

Symes, M O, W. Jaffe, Russell Jago, et al.. (1972). OBSERVATIONS ON THE EFFECT OF HORSE ANTIPIG LEUCOCYTE SERA IN SUPPRESSING THE REJECTION OF RENAL ALLOGRAFTS IN PIGS. Transplantation. 13(3). 218–223. 1 indexed citations

16.

Symes, M O, et al.. (1971). Gastric Ulceration and Haemorrhage as a Potential Cause of Experimental Failure Following Renal Allografting in Pigs. European Surgical Research. 3(6). 373–377. 4 indexed citations

17.

Symes, M O, et al.. (1971). Observations on the Increasing Malignancy of Tumours on Prolonged Growth: The Influence of Immunological Changes in the Host. British Journal of Cancer. 25(1). 121–129. 4 indexed citations

18.

Symes, M O, et al.. (1968). Observations on the changing behaviour of AKR mouse lymphomas serially transplanted in the strain of origin.. PubMed. 15(3). 371–80. 8 indexed citations

19.

Symes, M O. (1965). Further Observations on the Growth of Mouse Mammary Carcinomata in the Strain of Origin. British Journal of Cancer. 19(1). 181–188. 4 indexed citations

20.

Woodruff, M. F. A., M O Symes, & N. Anderson. (1963). The Effect of Intraperitoneal Injection of Thoracic Duct Lymphocytes from Normal and Immunized Rats in Mice Inoculated with the Landschutz Ascites Tumour. British Journal of Cancer. 17(3). 482–486. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact